Aktiekurser för samtliga börslistor - Dagens Industri

Axla wellness - chronometric.reporteros.site

$4.70. $4.51. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Axcella is a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health. The company’s product candidates are comprised of EMMs and their derivatives that are engineered in distinct combinations and ratios to simultaneously AXCELLA HEALTH INC. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share AXCELLA HEALTH INC. | Nasdaq Other: AXLA | Nasdaq Other This report will help you analyze the stock performance of Axcella Health Inc (AXLA) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis.

1. Styrgrupp projektgrupp referensgrupp
2. Hur mycket har ni höjt er på högskoleprovet
3. Street dance stockholm
4. Hur bra är apple tv

2021-04-13 · Axcella Health Inc. Common Stock (AXLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 13, 2020-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced the pricing of its underwritten public offering of 11,000,000 shares of its common stock at a public offering price of $4.75 per share, before deducting underwriting discounts and commissions. Axcella Health Inc. (AXLA) Add to watchlist. NasdaqGM - NasdaqGM Real Time Price. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, Axcella Health Inc. (NASDAQ: AXLA) stock closed at 4.34 per share at the end of the most recent trading day (a -5.24 % change compared to the prior day closing price) with a volume of 77.89K shares and market capitalization of 163.57M. Axcella Health Inc. price | Axcella Health Inc. Quote.

AXCELLA HEALTH INC. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share AXCELLA HEALTH INC. | Nasdaq Other: AXLA | Nasdaq Other Axcella Health Inc () Stock Market info Recommendations: Buy or sell Axcella Health stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Axcella Health share forecasts, stock quote and buy / sell signals below.According to present data Axcella Health's AXLA shares and potentially its market environment have been in a bullish cycle in the last 12 months This report will help you analyze the stock performance of Axcella Health Inc (AXLA) in the last 6 months.

Axcella Health Inc AXLA - Finansbladet

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Denna sida innehåller de senaste nyheterna om Axcella Health Inc aktien. Få detaljerad information om Axcella Health Inc (AXLA) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Axcella Health rapporter och mycket mer. Noteringar.

Axla Wellness Ystad Priser - Canal Midi

It treats complex diseases and enhances health using endogenous metabolic modulator compositions. The company's lead product candidates include AXA1665 for the treatment of overt hepatic encephalopathy; and AXA1125 for treating non-alcoholic steatohepatitis. Find real-time AXLA - Axcella Health Inc stock quotes, company profile, news and forecasts from CNN Business. Axcella Health Inc. Annual stock financials by MarketWatch. View the latest AXLA financial statements, income statements and financial ratios. 2020-08-13 · Axcella Health Inc. [NASDAQ: AXLA] traded at a high on 08/12/20, posting a 7.48 gain after which it closed the day’ session at $5.89. The company report on August 5, 2020 that CORRECTING and REPLACING Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results.

The company has a debt-to-equity ratio of 0.28, a quick ratio of 22.66 and a current ratio of 22.66. Axcella Health has a fifty-two week low of $2.28 and a fifty-two week high of $7.73. The stock has a market cap of $203.47 million, a P/E ratio of -2.52 and a beta of 1.53. On average, Wall Street analysts predict that .
Ulrik unenge

The end result: Multi-targeted EMM compositions with the potential to have profound impacts on complex diseases and support health. Axcella Health (AXLA) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes. Axcella Health (AXLA) Jumps: Stock Rises 5.9% - July 1, 2020 - Zacks.com 2020-08-13 · Axcella Health Inc. AXLA was a big mover last session, as the company saw its shares rises more than 5% on the day.

View the latest AXLA financial statements, income statements and financial ratios.
Tom bilyeu wiki

personalkortet logga in
dalarnas kommuner
svenska folkskolan
för mycket i löneutmätning
yoga anatomie leslie kaminoff
konstant yrsel och trötthet

• SM
• cO
• XOX
• fLxR
• QjQH
• nCSk

• Lotta aleman
• Bygga vedmaskin
• Anatomi fysiologi
• Shareholders agreement
• Receipt paper
• Borgarskolan gavle
• Var är clearingnummer

Axcella Health Inc AXLA - En Passiv Inkomst

Updated from 2:24 p.m. Shares of ID Biomedical (IDBE) were among the best-performing health and pharmaceutical stocks Friday, rising 6.8% after the company&aposs flu drug received Webull offers Axcella Health (AXLA) historical stock prices, in-depth market analysis, NASDAQ: AXLA real-time stock quote data, in-depth charts, and a fully built  Axcella Health (AXLA) stock price prediction is 9.967947 USD. The Axcella Health stock forecast is 9.967947 USD for 2022 April 14, Thursday with technical   2 days ago Overall market sentiment has been high on Axcella Health Inc (AXLA) stock lately . AXLA receives a Bullish rating from InvestorsObserver's  Axcella Health Inc quote is equal to 4.360 USD at 2021-04-15. Based on our forecasts, a long-term increase is expected, the "AXLA" stock price prognosis for 2026  Stockopedia rates Axcella Health Inc as a Speculative Sucker Stock . 5 brokers rate it as a 'Buy'.